Färber, L, Haus, U, Späth, M et al. · Scandinavian journal of rheumatology. Supplement · 2004
This review examines how a specific brain chemical receptor called 5-HT3 works in the body and what happens when it malfunctions. The researchers found that blocking this receptor with certain medications may help treat several conditions, including ME/CFS, by reducing symptoms like nausea, pain, and anxiety. However, scientists still don't fully understand exactly how this receptor causes problems in these different illnesses.
ME/CFS appears on the clinical indication list for 5-HT3 antagonists, suggesting serotonin dysregulation may contribute to ME/CFS pathophysiology. Understanding the 5-HT3 receptor's role in autonomic regulation, pain processing, and immune function could identify new treatment targets for ME/CFS patients who suffer from gastrointestinal, neurological, and pain-related symptoms.
This review does not prove that 5-HT3 receptor antagonists are effective treatments for ME/CFS—it only mentions ME/CFS as a possible indication based on emerging data. The study does not establish causation or demonstrate that serotonin dysregulation is the primary pathological mechanism in ME/CFS. It also does not clarify why dose-response curves are inconsistent or explain conflicting experimental findings.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Färber, L, Haus, U, Späth, M, & Drechsler, S (2004). Physiology and pathophysiology of the 5-HT3 receptor.. Scandinavian journal of rheumatology. Supplement. https://pubmed.ncbi.nlm.nih.gov/15515404/
BibTeX
@article{mecfsatlas-frber-2004-physiology-pathophysiology,
author = {Färber, L and Haus, U and Späth, M and Drechsler, S},
title = {Physiology and pathophysiology of the 5-HT3 receptor.},
journal = {Scandinavian journal of rheumatology. Supplement},
year = {2004},
note = {PubMed: 15515404},
url = {https://www.mecfsatlas.com/evidence/frber-2004-physiology-pathophysiology},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-26. https://www.mecfsatlas.com/evidence/frber-2004-physiology-pathophysiology
Contribute
Private, reviewed by a human. Not a public comment thread.